which in the main has now been superseded by peripheral blood stem cell transplant (PBSCT) which is associated with earlier haemopoietic reconstitution and less transplantAutologous GVHD was induced using CsA and ␣-IFN in a patient undergoing autologous PBSCT for accelerrelated morbidity and mortality. In this paper, we show that it was possible to induce autologous GVHD by CsA/alpha ated phase CML. We demonstrated that the autologous mixed lymphocyte reactions were extremely sensitive interferon (␣-IFN) following PBSCT in a patient with accelerated phase CML. We also demonstrate the extreme and specific for the detection of the GVHD when compared to skin biopsy. The resultant autologous GVHD sensitivity and specificity of using autologous mixed lymphocyte reactions instead of skin biopsy to detect and moniwas associated with an in vitro GVL effect, suggesting a potential clinical benefit of this therapeutic tor the GVHD. Furthermore, the autologous GVHD also exhibited a possible GVL effect. manoeuvre. The post-PBSCT period was associated with an improvement in normal haemopoiesis and reduction in the proportion of blood cells expressing the Philadelphia chromosome.
2 ), cytosine (3 g/m 2 ) and etoposide (450 mg/m 2 ). treated with cyclosporin A (CsA). 4 Such an experimental However, the white blood cell counts were difficult to conmanoeuvre, either with CsA alone or in combination with trol. He also had progressive splenomegaly, suggesting that cytokines, 5, 6 has since been used clinically. Although most he had entered the accelerated phase of his disease. of these patients developed autologous GVHD, the disease To induce autologous GVHD, a 28-day continuous intrahas been confined to mild skin rash and its clinical relvenous infusion of CsA (1 mg/kg/day) starting day +1 postevance in terms of the graft-versus-leukaemia (GVL) effect PBSCT was administered. ␣-IFN given subcutaneously was remains to be determined. Furthermore, all these cases have added at an increasing dose starting day +10 (3 MU/week been carried out mainly in the setting of autologous BMT, for the first week and increased gradually to 3 MU three times a week after 3 weeks). The peri-transplant period was uneventful. His neutrophil counts reached 0.5 × 10 whilst on CsA and another on day +30 after stopping CsA. Both episodes of skin rash were clinically consistent with an acute GVHD. The second episode of skin rash was also associated with a self-limiting diarrhoea. The histology of the first skin biopsy showed only a very mild non-specific dermatitis, suggesting that the rash may be drug-induced. Histology of the second skin biopsy showed a mild perivascular lymphocytic infiltration in the dermis together with a prominent intraepidermal lymphocytic infiltration with accompanying basal cell vacuolar changes and ballooning degeneration of the squamous cells ( Figure 1 ). Immunocytochemical staining indicated that these lymphocytes consisted of a combination of CD4 + and CD8
+ subpopulations and expressed strong CD3 and HLA-DR surface markers, suggesting that they were activated T cells. These features therefore support the clinical diagnosis PBSCT when exposed to autologous irradiated lymphocytes or leukaemia cells. SI was 1 during the first episode of skin rash but increased a week
Weekly peripheral blood lymphocytes were collected prior to the development of acute skin GVHD.
from the patient after PBSCT. They were used in autologous mixed lymphocyte reactions to detect the development of autologous GVHD. These lymphocytes were used both certain degree of normal haemopoiesis. Six months following PBSCT and induction of autologous GVHD, the patient as responder and stimulator cells. All reactions were carried out in triplicate. Figure 2 shows the weekly stimulation remained clinically well on ␣-IFN 3 MU five times a week and in complete haematological remission with resolution index (SI = 3 H-thymidine uptake in mixed lymphocyte reactions/basal 3 H-thymidine uptake) of the reactions. of splenomegaly. Autologous T lymphocyte reactivity was detected starting week 3 following PBSCT. This occurred 1 week prior to the development of the second episode of skin rash. The Discussion autoreactivity of the T cells persisted for a longer period than the skin rash. The autologous GVHD appeared to also
The ability to induce autologous GVHD following PBSCT in advanced stage CML was first described by Carella et exhibit a GVL effect since similar stimulation indices were obtained when irradiated autologous leukaemia cells were al. 7 However, unlike the previous study, 7 we have used a combination of CsA and ␣-IFN following PBSCT to induce used as the stimulator cells (Figure 2) .
We also carried out repeat bone marrow and peripheral autologous GVHD in a patient with accelerated phase CML. We confirmed that induction of autologous GVHD blood cytogenetic analysis. Prior to the transplant, haemopoiesis was 100% Ph+ve, as determined by cytogenetics of is possible following PBSCT in advanced CML. In addition, we have also demonstrated that autologous mixed the peripheral blood and bone marrow. Following PBSCT, although the bone marrow cells were still 100% Ph+ve, the lymphocyte reactions were extremely sensitive in detecting autologous GVHD. It occurred 1 week prior to the appearunstimulated peripheral blood cells consistently showed up to 100% normal cytogenetics, suggesting restoration of a ance of skin rash and persisted for a longer period than the skin rash. The low stimulation indices obtained during the first episode of skin rash also provided firm evidence to indicate that the skin rash was non-specific in nature. These results therefore suggest that, instead of skin biopsy, autologous mixed lymphocyte reaction could be used as a sensitive, specific and less invasive method for the detection and monitoring of autologous GVHD. The autologous GVHD appeared to be associated with a GVL effect since the T cells were also able to proliferate in response to autologous leukaemia cells, suggesting a potential clinical benefit of such a therapeutic manoeuvre. Whether or not there was a distinct GVL phenomenon not related to GVHD remains to be determined. The pre-transplant peripheral blood cytogenetics were consistently 100% Ph+ve. Following PBSCT this was markedly reduced suggesting restoration of a certain degree of normal haemopoiesis. However, this was not associated with any change in the cytogenetics of the bone marrow ancies between the cytogenetics of the peripheral blood and relevance of the induction of autologous GVHD following
